Latest GlaxoSmithKline Stories
AVP-825, Using OptiNose's Patented Bi-Directional(TM) Breath Powered(TM) Technology for Intranasal Delivery of Low-dose Sumatriptan, Demonstrates Greater Reduction in Migraine Pain Compared to the
LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Leading Nasal Strips Brand Has Signed An Official Partnership With The Famed Race Horse ELMONT, N.Y., June 5, 2014 /PRNewswire/ -- As online chatter of nasal strips continues to swell,
ReportsnReports.com adds “Country Focus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam” to its store.
Ultimate Herpes Protocol reviews have been flooding the Internet and have caught the attention of health writer Laura O'Connor prompting her to review the program that claims to quickly, naturally,
There is “an increased frequency of latent EBV-infected B cells in MS,” according to a study published in Acta Neurologica Scandinavica on March 31, 2014 (1).
LONDON, May 19, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
“Since October 2007, the cost of brand-name medicines has soared, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure,
Anger leaves “your weary body more vulnerable to viruses and illness,” according to an article published on March 14, 2014 on TheAustralian.com.au (1).
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.